Cochrane · systematic review · CD015422
Topical repellents for malaria prevention
Gabaldón Figueira, JC, Wagah, MG, Adipo, LB, et al. · Cochrane Database of Systematic Reviews · 2023 · Cochrane Library
Infectious DiseasesAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
5
current version
GRADE rated
4
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 1 · 20%Very low 0 · 0%Low 4 · 80%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Topical repellents versus placebo or no treatment in adults and children living in malaria‐endemic areas
Population: adults and children in malaria‐endemic areas
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Malaria infection incidence alone( Topical repellents vs placebo or no treatment | Rate ratio 0.76 [0.56, 1.02] | 1 study · 12813 participants | Low Downgraded: risk of bias, imprecision, indirectness |
Malaria case incidence alone( Topical repellents vs placebo or no treatment | Rate ratio 0.66 [0.32, 1.36] | 48838 participants | Low Downgraded: risk of bias, imprecision, indirectness |
Malaria case and infection incidence together ( Topical repellents vs placebo or no treatment | Rate ratio 0.74 [0.56, 0.98] | 1 study · 61651 participants | Low Downgraded: risk of bias, imprecision, indirectness |
Adverse events Topical repellents vs placebo or no treatment | no estimate extracted | 1 study · 47515 participants | Ungraded |
Malaria prevalence ( Topical repellents vs placebo or no treatment | Odds ratio 0.81 [0.67, 0.97] | 1 study · 55366 participants | Low Downgraded: risk of bias, imprecision, indirectness |